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PRECLINICAL STUDY
evelopment of Mild Aortic Valve
tenosis in a Rabbit Model of Hypertension
uis A. Cuniberti, PHD,* Pablo G. Stutzbach, FACC, MD,† Eduardo Guevara, FACC, MD,†
ustavo G. Yannarelli, MSC,* Rubén P. Laguens, MD, PHD,† Roberto R. Favaloro, MD, PHD†
uenos Aires, Argentina
OBJECTIVES This study was designed to investigate the association between hypertension and aortic valve
stenosis (AVS) in a rabbit model.
BACKGROUND Degenerative AVS is a prevalent disease in elderly persons. Its molecular mechanisms remain
unclear, in part because of the absence of experimental models. Epidemiologic data suggest
a link between hypertension and AVS. However, there has been no evidence of a cause-effect
relationship.
METHODS New Zealand White rabbits were divided into two groups: 1) animals (n  20) instrumented
according to one-kidney/one-clip hypertensive model; and 2) control animals (n  10) sham
operated. Echocardiography (S12 MHz) was used to assess aortic valve (AV) morphology and
function as well as left ventricular mass at baseline and after two and four months of
hypertension.
RESULTS Blood pressure and left ventricular mass increase were highly significant in the animal model
but not in controls at two months, without noticeable AV function abnormalities. After 4
months, however, 14 hypertensive survived animals showed a 14.6% reduction of AV area
(0.240  0.063 cm2 vs. 0.205  0.060 cm2, p  0.05), a 19.6% increase of AV thickness
(0.056 0.011 cm vs. 0.067 0.010 cm, p 0.001), a 40.4% increase of transvalvular mean
gradient (5.35  2.26 mm Hg vs. 7.51  3.73 mm Hg, p  0.05) and a 63.6% increase of
transvalvular maximal gradient (10.56  3.68 mm Hg vs. 17.28  10.95 mm Hg, p  0.05).
Control animals did not show significant changes.
CONCLUSIONS We report a novel experimental model of AVS in rabbits that may prove useful in studying
the progression of the disease and the efficacy of new treatments. The present findings support
the hypothesis of a causal link between hypertension and AVS. (J Am Coll Cardiol 2006;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.12.07047:2303–9) © 2006 by the American College of Cardiology Foundation
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sortic valve stenosis (AVS) is a chronic progressive condi-
ion and is the most common form of acquired valve heart
isease in developed countries (1). Despite the incidence of
egenerative AVS and its increasing associated morbidity
nd mortality, the molecular and cellular mechanisms of this
isorder remain unclear, in part because of the absence of
ppropriate experimental models (2–4). Epidemiologic
tudies have identified several atherosclerotic risk factors for
he progression and outcome of AVS, including age, smok-
ng, high cholesterol levels, low high-density lipoprotein
holesterol levels, hypertension (HTA), lipoprotein(a) lev-
ls, and diabetes (5–12). Although recent observations have
einforced the suggested association between HTA and the
evelopment of AVS (13,14), comorbidities associated with
igh blood pressure (high blood cholesterol, hyperinsulin-
mia, and so on) might be relevant confounding factors
athologically related to AVS progression, and so far no
ertain evidence of a causal link has been found. In fact,
merging animal models of AVS have focused on the
From the *Lipid and Atherosclerosis Research Laboratory, Department of Pathol-
gy, Favaloro University, Buenos Aires, Argentina; and the †Institute of Cardiology
nd Cardiovascular Surgery of the Favaloro Foundation, Buenos Aires, Argentina.
his work was supported by grant CID 107 from Favaloro University.m
Manuscript received August 22, 2005; revised manuscript received October 6,
005, revised December 13, 2005.evelopment of AVS essentially using hypercholesterolemic
onditions as valvular insult (15–17).
Histologic studies show that an early step in the
rogression of AVS is oxidized lipid and lipoprotein
epositions, macrophage and T-lymphocyte infiltration,
nd microscopic calcification, particularly in the aortic
ide of the valve (18,19). This prominent feature fits with
he notion that arterial segments subjected to turbulent
lood flow, such as those at branch points or arterial
urfaces of aortic valve cups, show a predisposition to
esion development that is intensified by hypertension
20 –22). A possible mechanism that could explain the
eleterious effects of HTA is, at least in part, the synergy
etween elevated blood pressure and other atherogenic
timuli to induce oxidative stress (23). The striking
orrelation between disturbed blood flow patterns and
therosclerosis has led to various recent studies (24,25) in
n attempt to define a mechanistic role for hemodynam-
cs forces in the pathogenesis of AVS.
We hypothesized that sustained hypertension per se
ould lead to valve damage with abnormalities in the valve’s
orphology and function. Therefore, the aim of the present
tudy was to investigate the development of AVS in a rabbit
odel of hypertension.
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nimals. Thirty adult New Zealand White rabbits (weight
.7 to 3.2 kg) were randomly divided into two groups: 1)
ypertensive animals (n  20) induced by one-kidney/one-
lip Goldblatt model (26), and 2) sham-operated normo-
ensive controls (n  10) with unilateral nephrectomy and
ontralateral renal artery non-clipping. Animals were
oused in individual cages, quarantined for seven days
efore surgery, fed normal chow and water ad libitum, and
reated according to the Guide for the Care and Use of
aboratory Animals published by the U.S. National Insti-
utes of Health.
Direct blood pressure measurements and blood samples
ere obtained from all animals before the surgical procedure
nd two and four months thereafter through catheterization
f the central ear artery. Serum samples were immediately
rozen and kept at 80°C until laboratory determinations
ere carried out.
chocardiography. Transthoracic echocardiography was
erformed by applying standard practice guidelines at base-
ine and at two and four months of follow-up. Animals were
edated with an intramuscular injection of ketamine (20
g/kg) and xilazine (1 mg/kg). Ultrasound images were
btained with a 12-MHz phased-array probe connected to
Sonos 5500 echograph (Philips Medical Imaging, An-
over, Massachusetts). A parasternal short-axis view at the
id left ventricular (LV) level was used to measure the
ollowing parameters: LV end-systolic and end-diastolic
imensions and ventricular septum and LV posterior wall
hickness. The LV mass was measured by M-mode echo-
ardiography with the use of the Devereux formula (27).
elative wall thickness (RWT) was measured as RWT 
 (PWT/LVIDd). The peak and mean aortic valve flow
elocities were determined by continuous-wave Doppler
chocardiography by systematically sampling the flow from
ifferent windows and averaging the values for four to five
eats. The maximal instantaneous gradient across the aortic
alve and the mean gradient were derived from aortic
oppler velocities by the modified Bernoulli equation. The
ortic valve area was measured by the standard continuity
quation in the same manner as in humans with suspected
VS (28). To minimize the intra- and inter-assay variabil-
ty, all echocardiographic imaging and analyses were carried
ut by the same investigator, who was kept blind regarding
Abbreviations and Acronyms
AV  aortic valve
AVS  aortic valve stenosis
HDL  high-density lipoprotein
HTA  hypertension
LV  left ventricular
PWT  posterior wall thickness
RWT  relative wall thicknessroup allocation of individual animals throughout the study.
*istology. After four months’ follow-up, rabbits received a
ethal anesthetic dose; the hearts were excised; and the aortic
alves were immediately dissected free of surrounding tissue,
insed in phosphate-buffered saline, and prepared for mac-
oscopic evaluation. One suitable leaflet from each aortic
alve was fixed in 4% neutral-buffered formalin and pro-
essed for paraffin embedding. Serial cross-sections (5-m
hick) were prepared with hematoxylin and eosin and
asson’s trichromic staining for histologic analysis.
tatistical analysis. Continuous variables are expressed as
ean  SD. Repeated-measurement one-way analysis of
ariance with the post hoc Newman-Kleus test was used for
ntragroup comparisons to assess changes in blood pressure
evels and echocardiographic parameters over time. The
npaired t test was used for intergroup comparisons. A
robability value 0.05 was considered statistically
ignificant.
ESULTS
linical and laboratory characteristics. All rabbits in the
ontrol group remained alive to the end of the study,
hereas six animals in the hypertensive group died prema-
urely (five from histologically verified hemorrhagic stroke
nd one from nonverified cause). Rabbits in group 1
niformly developed hypertension within two to three
eeks from surgery. As shown in Table 1, at two months
ystolic and diastolic blood pressure levels significantly
ncreased by 36.3% and 47%, respectively. Systolic, but not
iastolic, blood pressure levels additionally increased to
able 1. Clinical and Laboratory Characteristics Over Study
eriod
Group I
HTA
Group II
Control p Value
umber of rabbits
(M/F)
Baseline 20 (9/11) 10 (5/5) —
2 months 17 (8/9) 10 (5/5) —
4 months 14 (6/8) 10 (5/5) —
ody weight, kg
Baseline 3.1  0.4 2.9  0.4 NS
2 months 3.7  0.5* 3.6  0.4* NS
4 months 3.7  0.6* 3.7  0.5* NS
ystolic blood presure,
mm Hg
Baseline 102.9  6.4 99.0  7.4 NS
2 months 140.3  15.9* 99.0  5.2 0.0001
4 months 161.5  23.0*† 101.2  7.5 0.0001
iastolic blood presure,
mm Hg
Baseline 81.8  3.5 80.0  4.1 NS
2 months 120.2  16.1* 80.8  4.4 0.0001
4 months 119.8  16.3* 80.0  6.2 0.0001
otal cholesterol,
mg/dl
Baseline 84.2  30.1 86.2  34.6 NS
2 months 93.6  32.6 88.2  20.2 NS
4 months 93.2  19.8 92.8  32.7 NSp  0.001 compared with baseline; †p  0.001 compared with 2 months.
HTA  hypertension; NS  not significant.
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June 6, 2006:2303–9 Emerging Model of AVS in Rabbits6.9% over baseline at four months. Blood pressure levels
id not change in control animals throughout the study
eriod. Body weight increased similarly in animals from the
ontrol and the hypertensive groups (3.7  0.5 kg and 3.7 
.6 kg, respectively, pNS). Total plasma cholesterol levels
ere transiently and slightly higher after surgery to a similar
xtent in the control and the hypertensive group, but they
emained within the normal range throughout the study
92.8  32.7 mg/dl and 93.2  19.8 mg/dl, respectively,
 NS).
chocardiographic evaluation of AVS progression. As
hown in Table 2, the thickness of ventricular septum and
he LV posterior wall, as well as RWT and LV mass,
howed a highly significant increase after two and four
onths in the hypertensive group. At this time, aortic valve
AV) area significantly decreased by 14.6% (0.240  0.063
m2 vs. 0.205  0.060 cm2, p  0.05), whereas AV
hickness, transvalvular mean gradient, and transvalvular
aximal gradient significantly increased 19.6% (0.056 
.011 cm vs. 0.067  0.010 cm, p  0.001), 40.4% (5.35 
.26 mm Hg vs. 7.51 3.73 mm Hg, p 0.05), and 63.6%
able 2. Changes in Echocardiographic Characteristics Over
tudy Period
Group I
HTA
Group II
Control p Value
osterior wall
thickness, mm
Baseline 3.10  0.46 3.11  0.36 NS
2 months 3.57  0.53† 3.10  0.47 0.05
4 months 3.87  0.61†‡ 3.13  0.37 0.01
eptum thickness, mm
Baseline 3.00  0.41 3.06  0.38 NS
2 months 3.49  0.47† 3.01  0.36 0.01
4 months 3.64  0.54†‡ 2.79  0.28 0.001
V mass, g
Baseline 4.48  0.95 4.18  0.77 NS
2 months 5.22  1.07† 4.12  0.71 0.01
4 months 6.40  2.26† 3.93  0.81 0.01
alve thickness, cm
Baseline 0.056  0.011 0.055  0.007 NS
2 months 0.058  0.010 0.055  0.007 NS
4 months 0.067  0.010† 0.053  0.007 0.001
ortic valve area, cm2
Baseline 0.240  0.063 0.228  0.062 NS
2 months 0.256  0.077 0.222  0.048 NS
4 months 0.205  0.060*§ 0.236  0.041 NS
aximal gradient,
mm Hg
Baseline 10.56  3.68 10.98  3.88 NS
2 months 7.88  3.29 10.73  3.57 NS
4 months 17.28  10.95*§ 9.15  3.64 0.05
ean gradient,
mm Hg
Baseline 5.35  2.26 5.07  1.93 NS
2 months 4.43  2.47 4.84  1.58 NS
4 months 7.51  3.73*‡ 4.14  1.47 0.05
p  0.05; †p  0.001 compared with baseline; ‡p  0.05; §p  0.01; p  0.001
ompared with 2 months.
HTA  hypertension; LV  left ventricular; NS  not significant.10.56  3.68 mm Hg vs. 17.28  10.95 mm Hg, p  c.05), respectively, in the hypertensive group. None of these
chocardiographic changes was evident in the control group
Fig. 1). An intergroup comparison at four months revealed
hat the hypertensive condition was associated with valve
hickening (26.4%, p  0.001), increased transvalvular
ean gradient (81.4%, p  0.05), increased transvalvular
aximal gradient (88.9%, p  0.05), and a nonsignificant
eduction of AV area (13.1%).
ssociation between severity of hypertension and AVS.
s shown in Table 3, at four months of follow-up there
ere positive associations between systolic blood pressure
nd echocardiographic measures of LV remodeling such as
eptum thickness (p  0.0001), posterior wall thickness
p  0.05), and LV mass (p  0.0005). Similarly, signifi-
ant associations were observed between systolic blood
ressure and measures of AVS, including valve thickness
p 0.005) and maximal and mean gradients (p 0.01 and
 0.05, respectively). Finally, AV area changes did not
orrelate with a hypertensive state (p  0.10).
acroscopic and histologic evaluation. Visual examina-
ion of excised aortic valves from hypertensive animals
evealed a progressive degeneration of the leaflet morphol-
gy during follow-up. Whereas valves from control animals
ad a clear glistening appearance (Fig. 2A), those from
ypertensive animals presented signs of tissue hypertrophy
Figs. 2B and 2C). Microscopic analysis showed a promi-
ent lesion development on the aortic side of the valve
haracterized by inflammation nodules extending to the
ortic base and to the tip region of the leaflets (Fig. 3).
ISCUSSION
he progression of calcified AVS has long been considered
“wear and tear” phenomenon—a consequence of aging
oupled with increased hemodynamic/biomechanical
tresses on the aortic valve. For most of the patients
rogressing to severe stenosis, surgical intervention is re-
uired (29,30). More recently, classical risk factors for
therosclerotic disease were implicated as accelerating con-
itions of AVS. Although an association between hyperten-
ion and AVS has been reported almost uniformly in
ultiple clinical studies (5,6,12–14,31), most of these ob-
ervations have been limited by small sample size; possible
election bias; nonrandomization; cross-sectional nature;
etrospective study design; and comorbidities associated
ith hypertension, such as hypercholesterolemia, insulin
esistance, obesity, and so on.
To our knowledge, this study is the first to demonstrate a
irect association between experimental hypertension and
evelopment of aortic stenosis without the potential influ-
nce of common clinically relevant confounding factors.
he comparable results obtained by morphologic valve
ssessment, combined with functional echocardiographic
nalysis and histopathology examination, support our
onclusions.
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Emerging Model of AVS in Rabbits June 6, 2006:2303–9igure 1. Effect of hypertension (HTA) on aortic valve by echocardiographic assessment. Transthoracic echocardiography was used to measure the
ollowing morphologic and functional parameters at baseline and at two and four months of follow-up: valve thickness (A), aortic valve area (AVA) 
ontinuity (B), maximal gradient (C), and mean gradient (D) in hypertensive (left) and control rabbits (right).
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June 6, 2006:2303–9 Emerging Model of AVS in RabbitsThe association between hypertension and aortic valve
isease may find several explanations. Pathogenically, hy-
ertension may intensify the recognized hemodynamic dis-
urbances that affect the aortic side of the valve (25,32), and
his degenerative process could be accelerated in our study
y the coupled high cardiac frequency of the rabbit.
A prominent characteristic of degenerative aortic valvular
tenosis in humans is the presence of inflammatory infil-
rates composed of macrophages, T-cells, and lipids, par-
icularly in the fibrosa, the anatomic layer of the valve
ocated immediately below the endothelium on the aortic
ide of the valve (18). It is noteworthy that these character-
stics are strikingly similar to the histologic findings in our
odel of inflammatory nodules in the aortic side of the
alves, which suggest that the valvular lesions induced by
ypertension in the rabbit well reproduce one of the major
arly features of human valvular disease. Yet the precise
ubcellular/molecular mechanisms responsible for the in-
reased site-specific inflammatory activity of the valves
emain to be clarified.
In this study, we cannot exclude that various humoral/
etabolic modifications inherent to the experimental model
ight have contributed to the development of valvular
isease, including electrolyte imbalances, hyperreninemia,
yperaldosteronemia, other neurohormonal changes, or a
igure 2. Aortic valve photographs from rabbits over study period. The a
Table 3. Relationship Between Echocardiograp
Four Months of Follow-Up
85–119
(n  10)
(A)
PWT, mm 3.13  0.40
Septum thickness, mm 2.79  0.28
RWT 0.448  0.074
LV mass, g 3.94  0.81
Valve thickness, cm 0.053  0.007
Aortic valve area, cm2 0.236  0.041
Maximal gradient, mm Hg 9.15  3.64
Mean gradient, mm Hg 4.14  1.47
p values derived from one-way ANOVA after Newman-Kleu
0.05 compared with B.
LV left ventricular; NS not significant; PWT poste
blood pressure.B) hypertension (HTA) after two months; (C) HTA after four months. The co
ypertensive animals show marked signs of tissue hypertrophy after four monthild loss of renal function. Yet, one or more of these
arameters are also commonly altered in patients with
ypertension, which makes the model even more evocative
f the human condition.
Another advantage of this study as compared to other
revious experimental models of AVS is its use of two-
imensional Doppler echocardiography as the test of choice
o assess valve morphology and to quantify the extent of
hanges in valvular function. This is pertinent in that this
iagnostic tool is considered the “noninvasive gold stan-
ard” for the diagnosis of aortic valve stenosis (33). This
pproach was recently proposed by Drolet et al. (16) and
as successfully reproduced in the present study.
Although the ultrasonographic cardiac assessment of
mall animals may raise practical difficulties and inaccura-
ies, the method may be useful and show fair reproducibility
n middle-size animals such as the rabbits weighing around
.7 kg used in this protocol.
Unlike other previously published models of hypertension
nduced by acute pressure overload (34,35), the model used in
his study more suitably reproduces a chronic hypertensive state
36). Some of our notable findings can be summarized as
ollows: 1) a drop in transvalvular gradients at two months,
hich indicates that intraventricular pressure is conserved in
ypertensive early state; and 2) a heterogeneous response to
valve is shown from the ascending aorta. (A) Control after four months;
arameters and Systolic Blood Pressure at
BP (mm Hg)
p Value
120–149
(n  6)
(B)
150–180
(n  8)
(C)
78  0.65* 3.92  0.75* 0.05
43  0.41† 3.87  0.58‡ 0.0001
61  0.054† 0.584  0.078‡ 0.001
16  1.68† 7.11  1.92‡ 0.0005
68  0.010* 0.067  0.010† 0.005
29  0.040 0.184  0.063 NS
59  3.65 21.30  12.37†§ 0.01
36  3.18 8.01  4.29* 0.05
*p  0.05; †p  0.01; ‡p  0.001 compared with A; §p 
all thickness; RWT relative wall thickness; SBP systolicortichic P
S
3.
3.
0.5
6.
0.0
0.2
11.
6.
s test.ntrol aortic valves have a clear glistening appearance, whereas valves from
s.
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Emerging Model of AVS in Rabbits June 6, 2006:2303–9ustained hypertension in terms of mean gradient and valve
eaflet thickening, which indicates that valvular susceptibil-
ty to hemodynamic damage has a significant interindividual
ariability. This heterogeneous response likely mimics the
linical condition epidemiologically associated with progres-
ion of valvular aortic stenosis.
Although the present findings support a role for high
lood pressure in the pathogenesis of mild AVS, further
xperiments using other hypertensive models of experimen-
al chronic hypertension in different animal species should
e performed to confirm this association. Moreover, longer
erm studies (6 to 12 months) are required to evaluate
hether the early lesions induced by hypertension in our
odel will ultimately result in advanced disease with pro-
ressive leaflet thickening and eventually calcification and
evere aortic valve stenosis.
Finally, a role of atherogenic lipoproteins as risk factors,
ot only for classical atherosclerosis but also for aortic valve
tenosis, has recently been emphasized, and this notion is
upported by several sources of data. First, at least three
xperimental models of hypercholesterolemia-induced valve
alcification and stenosis were recently reported (15–17);
econd, high blood lipids are epidemiologically associated
ith progression of AVS; and third, there is some contro-
igure 3. Light microscopy of rabbit aortic valves after four months with
A) Low-magnification view (25); (B) high-magnification view (400)
hickness and development of inflammation nodules.ersial evidence that progression of AVS can be reduced by vtatins owing to their lipid-lowering activity and/or some of
heir pleiotropic effects.
Although in the studies reported herein the animals were
ormolipidemic, we cannot exclude a pathogenic role of
lood lipids. Indeed, hypertension augments infiltration of
acromolecules, proteins, and lipoproteins through the
ndothelial barrier and promotes vascular oxidative stress
23), potentially augmenting the susceptibility of the vessel
ven to physiologic plasma levels of atherogenic lipopro-
eins. Thus, we speculate that lipids beneath a hypertensive
tate, even within the normal range, may represent a continu-
us risk factor for AVS. Furthermore, it could be interesting to
ssess the ability of statins to prevent the progression of mild
VS in the hypertensive-normolipidemic rabbit model pre-
ented in this study.
In summary, we report here an experimental animal
odel of acquired AVS induced by high blood pressure,
hich may prove useful to investigate the precise mecha-
isms underlying the association between hypertension and
VS and the efficacy of different medical treatments to
elay, or even hinder, the advancement of the disease.
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